asean regional workshop on bilateral free trade agreements l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
ASEAN regional workshop on bilateral Free Trade Agreements PowerPoint Presentation
Download Presentation
ASEAN regional workshop on bilateral Free Trade Agreements

Loading in 2 Seconds...

play fullscreen
1 / 33

ASEAN regional workshop on bilateral Free Trade Agreements - PowerPoint PPT Presentation


  • 271 Views
  • Uploaded on

ASEAN regional workshop on bilateral Free Trade Agreements. Lessons from Latin american experience. Francisco Rossi. IP and access to drugs capacity building project. UNDP - International poverty centre. Brasilia. Brazil. Francisco.rossi@undp-povertycentre.org.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'ASEAN regional workshop on bilateral Free Trade Agreements' - paul


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
asean regional workshop on bilateral free trade agreements

ASEAN regional workshop on bilateral Free Trade Agreements

Lessons from

Latin american

experience

Francisco Rossi.

IP and access to drugs capacity building project.

UNDP - International poverty centre. Brasilia. Brazil.

Francisco.rossi@undp-povertycentre.org

asean regional workshop on bilateral free trade agreements2
ASEAN Regional workshop on bilateral Free Trade Agreements
  • The stronger the intellectual property rights, the better.
  • Negotiations with USA = Pharma.
  • Lessons from Latin America
  • On impact of IP
  • Next steps
slide4
Trips plus measures are totally legal.
  • Countries on FTA’s believe on IP
  • Countries on FTA’s decided sovereignty
  • FTA’s do not undermine Doha Declaration
  • Trips plus is unadequate term;

TRIPS PRECISSIONS.

drug makers go furthest to sway congress by jim drinkard usa today 26 04 05
  By the numbers$158 million*Spending in 2004 to lobby the federal government.$17 millionCampaign contributions in 2004 to federal candidates (67% to Republicans).$7.3 millionSupport for the 2004 political party conventions (64% to Republicans).* estimate; Sources: Center for Responsive Politics, Campaign Finance Institute, Center for Public IntegrityDrug makers go furthest to sway CongressBy Jim Drinkard, USA TODAY (26/04/05)
restrictions on inn generic names use
TRIPS 20

Other Requirements

The use of a trademark in the course of trade shall not be unjustifiably encumbered by special requirements, such as use with another trademark, use in a special form or use in a manner detrimental to its capability to distinguish the goods or services of one undertaking from those of other undertakings. This will not preclude a requirement prescribing the use of the trademark identifying the undertaking producing the goods or services along with, but without linking it to, the trademark distinguishing the specific goods or services in question of that undertaking.

CAFTA

ARTICLE 15.2 TRADEMARKS

In view of the obligations of Article 20 of the TRIPS Agreement, each Party shall ensure that provisions mandating the use of the term customary in common language as

the common name for a good (“common name”) including, inter alia, requirements concerning the relative size, placement or style of use of the trademark in relation to the common name, do not impair the use or effectiveness of trademarks used in relation to

such goods.

Restrictions on INN (generic names) use
intellectual property rights free trade agreements and public health11

Intellectual Property Rights, Free Trade Agreements and Public Health

Latin American Free Trade Agreements negotiations.

Lessons learned.

intellectual property rights free trade agreements and public health12
Intellectual Property Rights, Free Trade Agreements and Public Health

ON PROCESS

  • USTR: Agreements administrator.
  • Confidentiality
  • U.N. support. Carlos Correa Veto.
  • C.S.O.
  • CONGRESS
  • Health sector commitment : relations with trade negotiators
slide14

The agreement is not the end

Chilean experience with second uses.

intellectual property rights free trade agreements and public health15
Intellectual Property Rights, Free Trade Agreements and Public Health

AFTA PROPOSALS

Everything.

  • Patents for plants, animals, diagnostic, chirurgical and therapeutic methods.
  • Patents for uses
  • C.L. restrictions.
  • National exhaustion of rights

AFTA PROPOSALS

Everything.

  • Patent term restorations.
  • Linkage
  • Data protection
  • Restriction on generic names
intellectual property rights free trade agreements and public health16
Intellectual Property Rights, Free Trade Agreements and Public Health

AFTA PROPOSALS

  • USA PROPOSAL.
  • ANDEAN PROPOSAL. TRIPS-DOHA
  • 11 ROUNDS.
  • ANDEAN SECOND PROPOSAL
      • DATA PROTECTION
      • TRANSPARENCY
      • PATENT TERM RESTORATION
  • Colombian IP Negotiator impasse
  • Final political decision?
slide20

Fuente: Ramirez M. et al. El gasto en salud de los hogares Colombianos. Universidad del Rosario. 2002.

slide21

Spent on medicines as a % of income . Households survey. Colombia 1997

Fuente: Ramirez M. et al. El gasto en salud de los hogares Colombianos. Universidad del Rosario. 2002.

slide24
IPRC

The contemporary evidence suggests that, because developing countries are large net importers of technology from the developed world, the globalisation of IP protection will result in very substantial additional net transfers from developing to developed countries .

www.iprcommission.org

the stronger the intellectual property rights the better
The stronger the intellectual property rights, the better.
  • Benefits of innovation: ARV coverage
  • Innovation orientation: Neglected diseases
  • Innovation or stagnation? FDA Report.
  • Pharmaceutical industry: Research or marketing?
  • IP and development.
  • Technology transfer and FDI
ip and access to drugs capacity building project
IP and access to drugs capacity building project
  • No trips Plus (FTAs.)
  • National legislation on IP sensitive to public health. (Doha)
    • Full implementation of flexibilities
    • Full use of P 6 Resolution
  • South – South cooperation on generics
  • New international IP RULES?
spent us million and people on arv therapy
Spent (US $ million) and people on ARV therapy.

Source :MOH – STD/HIV-AIDS National Program. Brazil.

slide32

573

215

37%

106

21%

131

23%

19%

121

2003

3 imported (patented) ARVs mean 63% of total budget. 2003

12 other ARVs

37%

Spent

LPV.r+ EFZ+ NFV

63%

LPV.r

NFV

EFZ

12 other ARVs

Source :MOH – STD/HIV-AIDS National Program. Brazil.

slide33

4860

4540

4240

3810

3320

2223

2035

1996

1997

1998

1999

2000

2001

2002

Average cost of ARV patient/year

1996 - 2003

1630

2003

MS/ 2003

Source :MOH – STD/HIV-AIDS National Program. Brazil.